Population Pharmacokinetic Characteristics of Amikacin in Suspected Cases of Neonatal Sepsis in a Low-Resource African Setting: A Prospective Nonrandomized Single-Site Study
Background: Amikacin exhibits marked pharmacokinetic (PK) variability and is commonly used in combination with other drugs in the treatment of neonatal sepsis. There is a paucity of amikacin PK information in neonates from low-resource settings. Objectives: To determine the PK parameters of amikacin...
Saved in:
Main Authors: | Seth K. Amponsah, PhD (Author), George O. Adjei, MD, PhD (Author), Christabel Enweronu-Laryea, MRCPCH (Author), Kwasi A. Bugyei, PhD (Author), Kosta Hadji-Popovski, MSc Pharm (Author), Jorgen A.L. Kurtzhals, MD, PhD (Author), Kim Kristensen, PhD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of Ninjin'Yoeito on Fatigue in Patients Receiving Nab-Paclitaxel Plus Gemcitabine Therapy: A Prospective, Single-Arm, Phase II Open Label, Nonrandomized, Historically-Controlled Study
by: Ken-ichi Okada, MD, PhD, et al.
Published: (2020) -
Population Pharmacokinetic Estimates Suggest Elevated Clearance and Distribution Volume of Desethylamodiaquine in Pediatric Patients with Sickle Cell Disease Treated with Artesunate-Amodiaquine
by: George O. Adjei, MD, PhD, et al.
Published: (2019) -
Nonrandomized Impact Evaluation Studies
by: James E. Rohrer PhD, MS, BS
Published: (2010) -
Skin manifestations of suspected COVID-19: Complications of the disease or reactivation of latent viral infections?
by: Mariko Sugawara-Mikami, MD, PhD, et al.
Published: (2021) -
Effectiveness of Anise Oil for Treatment of Mild to Moderate Depression in Patients With Irritable Bowel Syndrome
by: Maryam Mosaffa-Jahromi PharmD, PhD, et al.
Published: (2017)